Results 221 to 230 of about 6,418,846 (364)

Deciphering metabolic reprogramming of immune cells within the tumor microenvironment. [PDF]

open access: yesJ Transl Med
Wang Y   +7 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Predictive Effectiveness of Circulating Tumor DNA in Recurrent Early-Stage Non-Small Cell Lung Cancer: An Updated Meta-Analysis. [PDF]

open access: yesJCO Precis Oncol
Lu D   +12 more
europepmc   +1 more source

Multi‐omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Using multi‐omic characterization, we aimed to identify key regulators specific to squamous cell lung carcinoma (SqCC). SqCC‐specific differentially expressed genes were integrated with metabolics data. High expression of the creatine transporter SLC6A8, along with elevated creatine levels, appeared to be a distinct metabolic feature of SqCC.
Johan Staaf   +10 more
wiley   +1 more source

Tumor-infiltrating lymphocytes-derived CD8<sup>+</sup> clonotypes infiltrate the tumor tissue and mediate tumor regression in glioblastoma. [PDF]

open access: yesOncoimmunology
Arruda LCM   +8 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

open access: yesNew England Journal of Medicine, 1991
N. Weidner   +3 more
semanticscholar   +1 more source

Breast microcalcifications as indicators of bone metastasis risk in early-stage breast cancer. [PDF]

open access: yesSci Rep
Giorello MB   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy